0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global MET TKIs Market Research Report 2026
Published Date: 2026-02-13
|
Report Code: QYRE-Auto-32L18018
Home | Market Reports
Global MET TKIs Market Research Report 2024
BUY CHAPTERS

Global MET TKIs Market Research Report 2026

Code: QYRE-Auto-32L18018
Report
2026-02-13
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

MET TKIs Market

The global MET TKIs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on MET TKIs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
MET tyrosine kinase inhibitors (TKIs) are targeted therapies designed to block the activity of the MET receptor tyrosine kinase.These inhibitors, including drugs like crizotinib, capmatinib, and tepotinib, are used to treat cancers with MET alterations, such as non-small cell lung cancer (NSCLC) and gastric cancer.
The North American market for MET TKIs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for MET TKIs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of MET TKIs include Pfizer, Novartis, Merck, Exelixis, Haihe Biopharma, CSPC Pharmaceutical, WuXi STA, Shanghai Hutchison Pharmaceuticals, Avistone Pharmaceuticals Biotechnology, Asymchem, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global MET TKIs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding MET TKIs. The MET TKIs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global MET TKIs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist MET TKIs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of MET TKIs Market Report

Report Metric Details
Report Name MET TKIs Market
Segment by Type
  • Multi-target Inhibitors
  • Single-target Inhibitors
by Application
  • Non-small Cell Lung Cancer
  • Medullary Thyroid Cancer
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Novartis, Merck, Exelixis, Haihe Biopharma, CSPC Pharmaceutical, WuXi STA, Shanghai Hutchison Pharmaceuticals, Avistone Pharmaceuticals Biotechnology, Asymchem, Wanbang Biopharmaceuticals, Drug International, Genvio Pharma, Everest Pharmaceuticals, Beacom, Teva, Cipla, BDR Pharma, Zydus
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for MET TKIs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines MET TKIs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the MET TKIs Market report?

Ans: The main players in the MET TKIs Market are Pfizer, Novartis, Merck, Exelixis, Haihe Biopharma, CSPC Pharmaceutical, WuXi STA, Shanghai Hutchison Pharmaceuticals, Avistone Pharmaceuticals Biotechnology, Asymchem, Wanbang Biopharmaceuticals, Drug International, Genvio Pharma, Everest Pharmaceuticals, Beacom, Teva, Cipla, BDR Pharma, Zydus

What are the Application segmentation covered in the MET TKIs Market report?

Ans: The Applications covered in the MET TKIs Market report are Non-small Cell Lung Cancer, Medullary Thyroid Cancer, Other

What are the Type segmentation covered in the MET TKIs Market report?

Ans: The Types covered in the MET TKIs Market report are Multi-target Inhibitors, Single-target Inhibitors

1 MET TKIs Market Overview
1.1 Product Definition
1.2 MET TKIs by Type
1.2.1 Global MET TKIs Market Value by Type: 2025 vs 2032
1.2.2 Multi-target Inhibitors
1.2.3 Single-target Inhibitors
1.3 MET TKIs by Application
1.3.1 Global MET TKIs Market Value by Application: 2025 vs 2032
1.3.2 Non-small Cell Lung Cancer
1.3.3 Medullary Thyroid Cancer
1.3.4 Other
1.4 Global MET TKIs Market Size Estimates and Forecasts
1.4.1 Global MET TKIs Revenue 2021–2032
1.4.2 Global MET TKIs Sales 2021–2032
1.4.3 Global MET TKIs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 MET TKIs Market Competition by Manufacturers
2.1 Global MET TKIs Sales Market Share by Manufacturers (2021–2026)
2.2 Global MET TKIs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global MET TKIs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of MET TKIs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of MET TKIs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of MET TKIs, Product Types and Applications
2.7 Global Key Manufacturers of MET TKIs, Date of Entry into the Industry
2.8 Global MET TKIs Market Competitive Situation and Trends
2.8.1 Global MET TKIs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global MET TKIs Players Market Share by Revenue
2.8.3 Global MET TKIs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global MET TKIs Market Scenario by Region
3.1 Global MET TKIs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global MET TKIs Sales by Region: 2021–2032
3.2.1 Global MET TKIs Sales by Region: 2021–2026
3.2.2 Global MET TKIs Sales by Region: 2027–2032
3.3 Global MET TKIs Revenue by Region: 2021–2032
3.3.1 Global MET TKIs Revenue by Region: 2021–2026
3.3.2 Global MET TKIs Revenue by Region: 2027–2032
3.4 North America MET TKIs Market Facts & Figures by Country
3.4.1 North America MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America MET TKIs Sales by Country (2021–2032)
3.4.3 North America MET TKIs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe MET TKIs Market Facts & Figures by Country
3.5.1 Europe MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe MET TKIs Sales by Country (2021–2032)
3.5.3 Europe MET TKIs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific MET TKIs Market Facts & Figures by Region
3.6.1 Asia Pacific MET TKIs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific MET TKIs Sales by Region (2021–2032)
3.6.3 Asia Pacific MET TKIs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America MET TKIs Market Facts & Figures by Country
3.7.1 Latin America MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America MET TKIs Sales by Country (2021–2032)
3.7.3 Latin America MET TKIs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa MET TKIs Market Facts & Figures by Country
3.8.1 Middle East and Africa MET TKIs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa MET TKIs Sales by Country (2021–2032)
3.8.3 Middle East and Africa MET TKIs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global MET TKIs Sales by Type (2021–2032)
4.1.1 Global MET TKIs Sales by Type (2021–2026)
4.1.2 Global MET TKIs Sales by Type (2027–2032)
4.1.3 Global MET TKIs Sales Market Share by Type (2021–2032)
4.2 Global MET TKIs Revenue by Type (2021–2032)
4.2.1 Global MET TKIs Revenue by Type (2021–2026)
4.2.2 Global MET TKIs Revenue by Type (2027–2032)
4.2.3 Global MET TKIs Revenue Market Share by Type (2021–2032)
4.3 Global MET TKIs Price by Type (2021–2032)
5 Segment by Application
5.1 Global MET TKIs Sales by Application (2021–2032)
5.1.1 Global MET TKIs Sales by Application (2021–2026)
5.1.2 Global MET TKIs Sales by Application (2027–2032)
5.1.3 Global MET TKIs Sales Market Share by Application (2021–2032)
5.2 Global MET TKIs Revenue by Application (2021–2032)
5.2.1 Global MET TKIs Revenue by Application (2021–2026)
5.2.2 Global MET TKIs Revenue by Application (2027–2032)
5.2.3 Global MET TKIs Revenue Market Share by Application (2021–2032)
5.3 Global MET TKIs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer MET TKIs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novartis MET TKIs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck MET TKIs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Exelixis
6.4.1 Exelixis Company Information
6.4.2 Exelixis Description and Business Overview
6.4.3 Exelixis MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Exelixis MET TKIs Product Portfolio
6.4.5 Exelixis Recent Developments/Updates
6.5 Haihe Biopharma
6.5.1 Haihe Biopharma Company Information
6.5.2 Haihe Biopharma Description and Business Overview
6.5.3 Haihe Biopharma MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Haihe Biopharma MET TKIs Product Portfolio
6.5.5 Haihe Biopharma Recent Developments/Updates
6.6 CSPC Pharmaceutical
6.6.1 CSPC Pharmaceutical Company Information
6.6.2 CSPC Pharmaceutical Description and Business Overview
6.6.3 CSPC Pharmaceutical MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 CSPC Pharmaceutical MET TKIs Product Portfolio
6.6.5 CSPC Pharmaceutical Recent Developments/Updates
6.7 WuXi STA
6.7.1 WuXi STA Company Information
6.7.2 WuXi STA Description and Business Overview
6.7.3 WuXi STA MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 WuXi STA MET TKIs Product Portfolio
6.7.5 WuXi STA Recent Developments/Updates
6.8 Shanghai Hutchison Pharmaceuticals
6.8.1 Shanghai Hutchison Pharmaceuticals Company Information
6.8.2 Shanghai Hutchison Pharmaceuticals Description and Business Overview
6.8.3 Shanghai Hutchison Pharmaceuticals MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Shanghai Hutchison Pharmaceuticals MET TKIs Product Portfolio
6.8.5 Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
6.9 Avistone Pharmaceuticals Biotechnology
6.9.1 Avistone Pharmaceuticals Biotechnology Company Information
6.9.2 Avistone Pharmaceuticals Biotechnology Description and Business Overview
6.9.3 Avistone Pharmaceuticals Biotechnology MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Avistone Pharmaceuticals Biotechnology MET TKIs Product Portfolio
6.9.5 Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
6.10 Asymchem
6.10.1 Asymchem Company Information
6.10.2 Asymchem Description and Business Overview
6.10.3 Asymchem MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Asymchem MET TKIs Product Portfolio
6.10.5 Asymchem Recent Developments/Updates
6.11 Wanbang Biopharmaceuticals
6.11.1 Wanbang Biopharmaceuticals Company Information
6.11.2 Wanbang Biopharmaceuticals Description and Business Overview
6.11.3 Wanbang Biopharmaceuticals MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wanbang Biopharmaceuticals MET TKIs Product Portfolio
6.11.5 Wanbang Biopharmaceuticals Recent Developments/Updates
6.12 Drug International
6.12.1 Drug International Company Information
6.12.2 Drug International Description and Business Overview
6.12.3 Drug International MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Drug International MET TKIs Product Portfolio
6.12.5 Drug International Recent Developments/Updates
6.13 Genvio Pharma
6.13.1 Genvio Pharma Company Information
6.13.2 Genvio Pharma Description and Business Overview
6.13.3 Genvio Pharma MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Genvio Pharma MET TKIs Product Portfolio
6.13.5 Genvio Pharma Recent Developments/Updates
6.14 Everest Pharmaceuticals
6.14.1 Everest Pharmaceuticals Company Information
6.14.2 Everest Pharmaceuticals Description and Business Overview
6.14.3 Everest Pharmaceuticals MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Everest Pharmaceuticals MET TKIs Product Portfolio
6.14.5 Everest Pharmaceuticals Recent Developments/Updates
6.15 Beacom
6.15.1 Beacom Company Information
6.15.2 Beacom Description and Business Overview
6.15.3 Beacom MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Beacom MET TKIs Product Portfolio
6.15.5 Beacom Recent Developments/Updates
6.16 Teva
6.16.1 Teva Company Information
6.16.2 Teva Description and Business Overview
6.16.3 Teva MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Teva MET TKIs Product Portfolio
6.16.5 Teva Recent Developments/Updates
6.17 Cipla
6.17.1 Cipla Company Information
6.17.2 Cipla Description and Business Overview
6.17.3 Cipla MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Cipla MET TKIs Product Portfolio
6.17.5 Cipla Recent Developments/Updates
6.18 BDR Pharma
6.18.1 BDR Pharma Company Information
6.18.2 BDR Pharma Description and Business Overview
6.18.3 BDR Pharma MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 BDR Pharma MET TKIs Product Portfolio
6.18.5 BDR Pharma Recent Developments/Updates
6.19 Zydus
6.19.1 Zydus Company Information
6.19.2 Zydus Description and Business Overview
6.19.3 Zydus MET TKIs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Zydus MET TKIs Product Portfolio
6.19.5 Zydus Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 MET TKIs Industry Chain Analysis
7.2 MET TKIs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 MET TKIs Production Mode & Process Analysis
7.4 MET TKIs Sales and Marketing
7.4.1 MET TKIs Sales Channels
7.4.2 MET TKIs Distributors
7.5 MET TKIs Customer Analysis
8 MET TKIs Market Dynamics
8.1 MET TKIs Industry Trends
8.2 MET TKIs Market Drivers
8.3 MET TKIs Market Challenges
8.4 MET TKIs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global MET TKIs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global MET TKIs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global MET TKIs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global MET TKIs Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global MET TKIs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global MET TKIs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global MET TKIs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market MET TKIs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of MET TKIs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of MET TKIs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of MET TKIs, Product Types and Applications
 Table 12. Global Key Manufacturers of MET TKIs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global MET TKIs Companies by Tier (Tier 1, Tier 2, Tier 3), based on MET TKIs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global MET TKIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global MET TKIs Sales by Region (K Units), 2021–2026
 Table 18. Global MET TKIs Sales Market Share by Region (2021–2026)
 Table 19. Global MET TKIs Sales by Region (K Units), 2027–2032
 Table 20. Global MET TKIs Sales Market Share by Region (2027–2032)
 Table 21. Global MET TKIs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global MET TKIs Revenue Market Share by Region (2021–2026)
 Table 23. Global MET TKIs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global MET TKIs Revenue Market Share by Region (2027–2032)
 Table 25. North America MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America MET TKIs Sales by Country (K Units), 2021–2026
 Table 27. North America MET TKIs Sales by Country (K Units), 2027–2032
 Table 28. North America MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe MET TKIs Sales by Country (K Units), 2021–2026
 Table 32. Europe MET TKIs Sales by Country (K Units), 2027–2032
 Table 33. Europe MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific MET TKIs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific MET TKIs Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific MET TKIs Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific MET TKIs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific MET TKIs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America MET TKIs Sales by Country (K Units), 2021–2026
 Table 42. Latin America MET TKIs Sales by Country (K Units), 2027–2032
 Table 43. Latin America MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa MET TKIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa MET TKIs Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa MET TKIs Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa MET TKIs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa MET TKIs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global MET TKIs Sales (K Units) by Type (2021–2026)
 Table 51. Global MET TKIs Sales (K Units) by Type (2027–2032)
 Table 52. Global MET TKIs Sales Market Share by Type (2021–2026)
 Table 53. Global MET TKIs Sales Market Share by Type (2027–2032)
 Table 54. Global MET TKIs Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global MET TKIs Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global MET TKIs Revenue Market Share by Type (2021–2026)
 Table 57. Global MET TKIs Revenue Market Share by Type (2027–2032)
 Table 58. Global MET TKIs Price (US$/Unit) by Type (2021–2026)
 Table 59. Global MET TKIs Price (US$/Unit) by Type (2027–2032)
 Table 60. Global MET TKIs Sales (K Units) by Application (2021–2026)
 Table 61. Global MET TKIs Sales (K Units) by Application (2027–2032)
 Table 62. Global MET TKIs Sales Market Share by Application (2021–2026)
 Table 63. Global MET TKIs Sales Market Share by Application (2027–2032)
 Table 64. Global MET TKIs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global MET TKIs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global MET TKIs Revenue Market Share by Application (2021–2026)
 Table 67. Global MET TKIs Revenue Market Share by Application (2027–2032)
 Table 68. Global MET TKIs Price (US$/Unit) by Application (2021–2026)
 Table 69. Global MET TKIs Price (US$/Unit) by Application (2027–2032)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Pfizer MET TKIs Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Novartis Company Information
 Table 76. Novartis Description and Business Overview
 Table 77. Novartis MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Novartis MET TKIs Product
 Table 79. Novartis Recent Developments/Updates
 Table 80. Merck Company Information
 Table 81. Merck Description and Business Overview
 Table 82. Merck MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Merck MET TKIs Product
 Table 84. Merck Recent Developments/Updates
 Table 85. Exelixis Company Information
 Table 86. Exelixis Description and Business Overview
 Table 87. Exelixis MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Exelixis MET TKIs Product
 Table 89. Exelixis Recent Developments/Updates
 Table 90. Haihe Biopharma Company Information
 Table 91. Haihe Biopharma Description and Business Overview
 Table 92. Haihe Biopharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Haihe Biopharma MET TKIs Product
 Table 94. Haihe Biopharma Recent Developments/Updates
 Table 95. CSPC Pharmaceutical Company Information
 Table 96. CSPC Pharmaceutical Description and Business Overview
 Table 97. CSPC Pharmaceutical MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. CSPC Pharmaceutical MET TKIs Product
 Table 99. CSPC Pharmaceutical Recent Developments/Updates
 Table 100. WuXi STA Company Information
 Table 101. WuXi STA Description and Business Overview
 Table 102. WuXi STA MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. WuXi STA MET TKIs Product
 Table 104. WuXi STA Recent Developments/Updates
 Table 105. Shanghai Hutchison Pharmaceuticals Company Information
 Table 106. Shanghai Hutchison Pharmaceuticals Description and Business Overview
 Table 107. Shanghai Hutchison Pharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Shanghai Hutchison Pharmaceuticals MET TKIs Product
 Table 109. Shanghai Hutchison Pharmaceuticals Recent Developments/Updates
 Table 110. Avistone Pharmaceuticals Biotechnology Company Information
 Table 111. Avistone Pharmaceuticals Biotechnology Description and Business Overview
 Table 112. Avistone Pharmaceuticals Biotechnology MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Avistone Pharmaceuticals Biotechnology MET TKIs Product
 Table 114. Avistone Pharmaceuticals Biotechnology Recent Developments/Updates
 Table 115. Asymchem Company Information
 Table 116. Asymchem Description and Business Overview
 Table 117. Asymchem MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Asymchem MET TKIs Product
 Table 119. Asymchem Recent Developments/Updates
 Table 120. Wanbang Biopharmaceuticals Company Information
 Table 121. Wanbang Biopharmaceuticals Description and Business Overview
 Table 122. Wanbang Biopharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Wanbang Biopharmaceuticals MET TKIs Product
 Table 124. Wanbang Biopharmaceuticals Recent Developments/Updates
 Table 125. Drug International Company Information
 Table 126. Drug International Description and Business Overview
 Table 127. Drug International MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Drug International MET TKIs Product
 Table 129. Drug International Recent Developments/Updates
 Table 130. Genvio Pharma Company Information
 Table 131. Genvio Pharma Description and Business Overview
 Table 132. Genvio Pharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Genvio Pharma MET TKIs Product
 Table 134. Genvio Pharma Recent Developments/Updates
 Table 135. Everest Pharmaceuticals Company Information
 Table 136. Everest Pharmaceuticals Description and Business Overview
 Table 137. Everest Pharmaceuticals MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Everest Pharmaceuticals MET TKIs Product
 Table 139. Everest Pharmaceuticals Recent Developments/Updates
 Table 140. Beacom Company Information
 Table 141. Beacom Description and Business Overview
 Table 142. Beacom MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Beacom MET TKIs Product
 Table 144. Beacom Recent Developments/Updates
 Table 145. Teva Company Information
 Table 146. Teva Description and Business Overview
 Table 147. Teva MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Teva MET TKIs Product
 Table 149. Teva Recent Developments/Updates
 Table 150. Cipla Company Information
 Table 151. Cipla Description and Business Overview
 Table 152. Cipla MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Cipla MET TKIs Product
 Table 154. Cipla Recent Developments/Updates
 Table 155. BDR Pharma Company Information
 Table 156. BDR Pharma Description and Business Overview
 Table 157. BDR Pharma MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. BDR Pharma MET TKIs Product
 Table 159. BDR Pharma Recent Developments/Updates
 Table 160. Zydus Company Information
 Table 161. Zydus Description and Business Overview
 Table 162. Zydus MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Zydus MET TKIs Product
 Table 164. Zydus Recent Developments/Updates
 Table 165. Key Raw Materials Lists
 Table 166. Raw Materials Key Suppliers Lists
 Table 167. MET TKIs Distributors List
 Table 168. MET TKIs Customers List
 Table 169. MET TKIs Market Trends
 Table 170. MET TKIs Market Drivers
 Table 171. MET TKIs Market Challenges
 Table 172. MET TKIs Market Restraints
 Table 173. Research Programs/Design for This Report
 Table 174. Key Data Information from Secondary Sources
 Table 175. Key Data Information from Primary Sources
 Table 176. Authors List of This Report


List of Figures
 Figure 1. Product Picture of MET TKIs
 Figure 2. Global MET TKIs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global MET TKIs Market Share by Type: 2025 & 2032
 Figure 4. Multi-target Inhibitors Product Picture
 Figure 5. Single-target Inhibitors Product Picture
 Figure 6. Global MET TKIs Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global MET TKIs Market Share by Application: 2025 & 2032
 Figure 8. Non-small Cell Lung Cancer
 Figure 9. Medullary Thyroid Cancer
 Figure 10. Other
 Figure 11. Global MET TKIs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global MET TKIs Market Size (US$ Million), 2021–2032
 Figure 13. Global MET TKIs Sales (K Units), 2021–2032
 Figure 14. Global MET TKIs Average Price (US$/Unit), 2021–2032
 Figure 15. MET TKIs Report Years Considered
 Figure 16. MET TKIs Sales Share by Manufacturers in 2025
 Figure 17. Global MET TKIs Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global MET TKIs Players: Market Share by Revenue in MET TKIs in 2025
 Figure 19. MET TKIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global MET TKIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America MET TKIs Sales Market Share by Country (2021–2032)
 Figure 22. North America MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 23. United States MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe MET TKIs Sales Market Share by Country (2021–2032)
 Figure 26. Europe MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 27. Germany MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific MET TKIs Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific MET TKIs Revenue Market Share by Region (2021–2032)
 Figure 34. China MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America MET TKIs Sales Market Share by Country (2021–2032)
 Figure 42. Latin America MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa MET TKIs Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa MET TKIs Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE MET TKIs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of MET TKIs by Type (2021–2032)
 Figure 53. Global Revenue Market Share of MET TKIs by Type (2021–2032)
 Figure 54. Global MET TKIs Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of MET TKIs by Application (2021–2032)
 Figure 56. Global Revenue Market Share of MET TKIs by Application (2021–2032)
 Figure 57. Global MET TKIs Price (US$/Unit) by Application (2021–2032)
 Figure 58. MET TKIs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String